EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases

Xiaoli Zhang, Yiming Ma, Guoqing Lv, Hongying Wang

Frontiers in Pharmacology · 13.01.2023 · 14

DOI: 10.3389/fphar.2023.1095366 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.01.2023. Verfasst von Xiaoli Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is an iron-dependent programmed cell death characterized by reactive oxygen species-induced lipid peroxidation and resultant membrane damage. Recent research has elucidated the mechanism of ferroptosis and investigated the relationship between ferroptosis and various diseases, including degenerative diseases, cancer, and inflammation. Ferroptosis is associated with inflammation-related intestinal diseases such as colitis and colitis-associated cancer. New insights into the role of ferroptosis in the pathogenesis of inflammation-related gut diseases have suggested novel therapeutic targets. In this review, we summarize current information on the molecular mechanisms of ferroptosis and describe its emerging role and therapeutic potential in inflammation-related intestinal diseases.

Schlagwörter

Stichwörter der Autor:innen

cell deathcolorectal cancerferroptosisinflammationinflammatory bowel disease

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Explosion Science and Technology, Beijing Institute of Technology, Beijing, China.
  • Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong, China.

Förderung

  • National Natural Science Foundation of China
  • Sanming Project of Medicine in Shenzhen

Zitieren

APA

Zhang, X., Ma, Y., Lv, G., & Wang, H. (2023). Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1095366

Vancouver

Zhang X, Ma Y, Lv G, Wang H. Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1095366

BibTeX
@article{Zhang2023,
  author = {Zhang, Xiaoli and Ma, Yiming and Lv, Guoqing and Wang, Hongying},
  title = {Ferroptosis as a therapeutic target for inflammation-related intestinal diseases},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1095366}
}
Kostenlos starten →